Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00043043 · ClinicalTrials.gov registry record · Phase 2
Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia
A Phase 2 study, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- Phase 2
- Development phase
NCT00043043: Completed Phase 2 study, sponsored by National Cancer Institute (NCI).
NCT00043043 is a Phase 2 study that has completed, run by National Cancer Institute (NCI). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00043043, a Phase 2 study, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Celecoxib may be effective in preventing colorectal cancer in patients who have a history of rectal polyps or colorectal neoplasia. PURPOSE: Randomized phase II trial to study the effectiveness of celecoxib in preventing colorectal cancer in patients who have a history of rectal polyps or colorectal neoplasia.
Interventions
- DRUG celecoxib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2003-05 |
| Est. Completion | 2007-10 |
| Phase | Phase 2 |
What the finished NCT00043043 record still lists
NCT00043043 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which celecoxib is the first listed.
NCT00043043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00043043 about?
NCT00043043 is a clinical study titled "Celecoxib in Preventing Cancer in Patients With Rectal Polyps or Colorectal Neoplasia". RATIONALE: Celecoxib may be effective in preventing colorectal cancer in patients who have a history of rectal polyps or colorectal neoplasia. PURPOSE: Randomized phase II trial to study the effectiveness of celecoxib in preventing colorectal cancer in patients who have a history of rectal polyps o...
What is the current status of trial NCT00043043?
This trial is currently completed. It is a Phase 2 study. The study started on 2003-05. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00043043?
The interventions under investigation include: celecoxib (DRUG).
Who is sponsoring clinical trial NCT00043043?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia